(Press-News.org) GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Pharmaceutics.
GLP-1 drugs such as semaglutide are widely used to treat type 2 diabetes and obesity. They do this by mimicking the action of GLP-1, a hormone that helps the body make more insulin when needed, slows down digestion, curbs appetite and increases feelings of fullness.
Many tissues around the body have GLP-1 receptors (proteins that respond to the hormone) and recent research has suggested the drugs also have anti-inflammatory and antioxidant effects.
For example, some studies have indicated they reduce the risk of diabetic retinopathy, the leading cause of blindness among working-age adults. More than 90% of people with type 1 diabetes and 50-60% of those with type 2 diabetes develop this condition, in which high blood sugar levels damage blood vessels in the light-sensitive tissue at the back of the eye.
“Diabetic retinopathy represents a major public health challenge,” says Ioanna Anastasiou, of the National and Kapodistrian University of Athens, Athens, Greece, who led the research. “Globally, it is projected that over 191 million people will be affected by it by 2030, with around 56 million experiencing vision-threatening stages of the disease.
“These statistics underscore the critical need for effective screening, early detection, and, crucially, more effective treatments.”
It is thought that much of the damage to the retina is done by free radicals, molecules that can damage cells and are produced in higher numbers when blood sugar is high. The theory is that GLP-1 drugs protect the retina by increasing levels of antioxidants, compounds that neutralise free radicals.
However, other studies have suggested that GLP-1 drugs increase the risk of diabetic retinopathy or exacerbate it in those who already have it.
To provide some clarity, Dr Anastasiou and colleagues carried out a detailed study of the effect of GLP-1 drugs on retinal cells in diabetes-like conditions.
For the lab-based study, human retinal endothelial cells were treated with a range of different concentrations of semaglutide. The cells were kept in media with high glucose levels and oxidative stress (in which there are more free radicals than antioxidants) for 24 hours.
They were then put through a series of tests. The results showed that the cells that were treated with semaglutide were up to twice as likely to still be alive than cells that were untreated. They also had larger stores of energy.
Three markers of oxidative stress in diabetic retinopathy were markedly lower in the treated cells: levels of apoptosis (a form of cell death) decreased from approximately 50% in untreated cells to about 10% in semaglutide-treated cells; the production of mitochondrial superoxide (a free radical) decreased from about 90% to about 10%; and the accumulation of harmful compounds called advanced glycation end-products also fell substantially.
Further analysis showed that genes involved in the production of antioxidants were upregulated, or more active, in the treated cells, compared with the untreated cells. This result – and the enhanced survival – indicate that semaglutide was repairing damage to the cells, says Dr Anastasiou.
Looked at as a whole, the results indicate that GLP-1 receptor agonists enhance retinal cells’ defences against damage in diabetes-like conditions.
Dr Anastasiou explains: “In experiments in the lab, GLP-1-receptor agonists exerted powerful antioxidant effects which protected retinal cells against the type of damage that can occur in diabetes.
“Our study did not find that these drugs harmed the retinal cells in any way – instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages.
“Excitingly, these drugs may be able to repair damage that has already been done and so improve sight.
“Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.”
END
Semaglutide provides powerful protection against diabetic retinopathy, the leading cause of blindness in working-age adults, Greek study suggests
2025-09-16
ELSE PRESS RELEASES FROM THIS DATE:
Orforglipron taken orally once daily leads to significant body weight loss (ATTAIN-1 Study)
2025-09-16
New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and simultaneously published in NEJM shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substantial weight loss in people living with obesity that do not have type 2 diabetes. The study is by Dr Sean Wharton, McMaster University, Hamilton, ON, Canada and Wharton Weight Management Clinic, Burlington, ON, Canada, and colleagues. The study is sponsored by Eli Lilly, the manufacturer of orforglipron.
Orforglipron is a small-molecule, ...
U of I researchers trace genetic code’s origins to early protein structures
2025-09-16
URBANA, Ill. – Genes are the building blocks of life, and the genetic code provides the instructions for the complex processes that make organisms function. But how and why did it come to be the way it is? A recent study from the University of Illinois Urbana-Champaign sheds new light on the origin and evolution of the genetic code, providing valuable insights for genetic engineering and bioinformatics.
“We find the origin of the genetic code mysteriously linked to the dipeptide composition of a proteome, the collective of proteins in an organism,” said corresponding author Gustavo Caetano-Anollés, professor in the Department ...
Disease experts team up with Florida Museum of Natural History to create a forecast for West Nile virus
2025-09-16
Key points
State and local officials in Florida maintain hundreds coops with what are referred to as sentinel chickens, which act as an early alarm system for the presence of mosquito-borne illnesses in an area. This alarm system just got an upgrade.
An interdisciplinary team of experts, including a zoonotic disease specialist, a museum data scientist and a salamander biologist, have combined their skills and created a statistical model that accurately predicts the activity of West Nile virus in an area up to six months in advance.
The model was trained using two decades of sentinel chicken data. The original data files ...
Researchers: Targeted efforts needed to stem fentanyl crisis
2025-09-16
A new study illuminates how some areas of the country have been hit much harder than others by the fentanyl epidemic, which took more than 70,800 lives in 2022 alone.
The research calls attention to a need for focused, coordinated efforts to prevent overdose deaths in the places where deaths from the opioid are rampant, said lead author Thomas Wickizer, a professor emeritus in The Ohio State University College of Public Health.
The study appears in the journal Health Affairs Scholar.
“We can look at this map and see there are certain areas which are experiencing this at an extremely dire rate, and energy and resources, including financial investments, should ...
New UMaine research could help lower prescription drug costs
2025-09-16
One of the main factors driving prices in pharmaceuticals, such as cholesterol-lowering drugs and antibiotics, is the cost of production and materials. Researchers at the University of Maine Forest Bioproducts Research Institute (FBRI) have discovered a sustainable method to produce the key ingredient in a broad range of pharmaceuticals, which could help address high prescription drug costs in the U.S.
Among some of the most expensive medications are those that require a chiral center ― a property in which a molecule cannot be superimposed with its mirror image, like right and ...
Molecular movie shows how mitochondria read their DNA
2025-09-16
Aging, neurological diseases and our bodies’ stress response are all linked to the tiny power plants inside each cell known as mitochondria. To function properly, mitochondria must first read instructions from their DNA and then copy it over into mRNA in a process called transcription. Now, researchers at Thomas Jefferson University have reconstructed transcription in human mitochondria in unprecedented detail. The findings, published in Molecular Cell, show how the molecular machinery works and reveal potential drug targets for mitochondrial diseases.
“When we understand ...
Loss of key male fertility gene leads to changes in expression of hundreds of other genes
2025-09-16
In a new study conducted at the University of Hawaiʻi at Mānoa, researchers from the John A. Burns School of Medicine (JABSOM) have shown that the loss of a key male fertility gene leads to infertility and changes expression of hundreds of other important genes.
The study was led by Professor Dr. Monika Ward from the Department of Anatomy, Biochemistry & Physiology and the Yanagimachi Institute for Biogenesis Research (YIBR). The team has been investigating a zinc finger Y-encoded gene called Zfy. This gene, encoded on Y chromosome in both mice and humans, is considered a male fertility factor. In mice, Zfy is present as two copies, Zfy1 and Zfy2.
The researchers ...
Water’s density is key to sustainable lithium mining
2025-09-16
AMHERST, Mass. — One of the biggest obstacles on the road to the low-carbon energy future is caused by the rare-earth element lithium, a critical component for the batteries that can store the abundant and sustainable energy from renewable sources. The element occurs naturally as a salt in briny oases, called salares, in some of the world’s harshest environments, including the “Lithium Triangle” high in South America’s arid Altiplano. Mining lithium has the potential to destabilize already sensitive environments that are host to rare flora and fauna, ...
Pioneering research reveals problem gambling quadruples the risk of suicide among young people four years later
2025-09-16
New research has shown how harmful gambling is clearly linked to a marked and long-lasting increase in suicide attempts among young people in the UK.
The study, by researchers at the University of Bristol, found that compared to someone who experiences no gambling harms, problem gamblers face triple the suicide risk one year later, and quadruple the risk four years on.
Researchers analysed data from 2,801 people in the renowned Children of the 90s study, which has followed the health and development of 14,000 pregnant women and their families since the early nineties, and which continues ...
New method improves the accuracy of machine-learned potentials for simulating catalysts
2025-09-16
Catalysts play an indispensable role in modern manufacturing. More than 80% of all manufactured products, from pharmaceuticals to plastics, rely on catalytic processes at some stage of production. Transition metals, in particular, stand out as highly effective catalysts because their partially filled d-orbitals allow them to easily exchange electrons with other molecules. This very property, however, makes them challenging to model accurately, requiring precise descriptions of their electronic structure.
Designing efficient transition-metal catalysts ...